| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thoracic Surgery | 96 | 2023 | 713 | 17.110 |
Why?
|
| Coronary Artery Bypass | 71 | 2022 | 2281 | 7.740 |
Why?
|
| Cardiac Surgical Procedures | 74 | 2023 | 3526 | 7.660 |
Why?
|
| Societies, Medical | 101 | 2023 | 3740 | 7.430 |
Why?
|
| Quality Indicators, Health Care | 32 | 2020 | 1831 | 4.780 |
Why?
|
| Databases, Factual | 74 | 2023 | 7716 | 3.620 |
Why?
|
| Quality Improvement | 29 | 2021 | 3738 | 2.920 |
Why?
|
| Heart Valve Prosthesis Implantation | 25 | 2023 | 1527 | 2.880 |
Why?
|
| Hospital Mortality | 50 | 2023 | 5310 | 2.740 |
Why?
|
| Cardiology | 28 | 2022 | 1658 | 2.700 |
Why?
|
| Quality Assurance, Health Care | 27 | 2019 | 2211 | 2.640 |
Why?
|
| Registries | 45 | 2022 | 8077 | 2.430 |
Why?
|
| Hospitals, Teaching | 7 | 2022 | 1179 | 2.220 |
Why?
|
| Heart Valve Diseases | 20 | 2021 | 1067 | 2.100 |
Why?
|
| Risk Adjustment | 17 | 2019 | 594 | 2.040 |
Why?
|
| Models, Statistical | 24 | 2021 | 5100 | 1.980 |
Why?
|
| Thoracic Surgical Procedures | 14 | 2018 | 341 | 1.790 |
Why?
|
| Benchmarking | 14 | 2021 | 1038 | 1.780 |
Why?
|
| Heart Defects, Congenital | 28 | 2023 | 4566 | 1.560 |
Why?
|
| Access to Information | 4 | 2016 | 320 | 1.560 |
Why?
|
| Postoperative Complications | 50 | 2023 | 15244 | 1.490 |
Why?
|
| Advisory Committees | 12 | 2017 | 773 | 1.360 |
Why?
|
| National Practitioner Data Bank | 3 | 2011 | 13 | 1.240 |
Why?
|
| Risk Assessment | 40 | 2022 | 23320 | 1.200 |
Why?
|
| Quality of Health Care | 19 | 2023 | 4369 | 1.180 |
Why?
|
| Aortic Valve Stenosis | 16 | 2021 | 1941 | 1.170 |
Why?
|
| United States | 125 | 2023 | 69693 | 1.160 |
Why?
|
| American Heart Association | 20 | 2020 | 1055 | 1.150 |
Why?
|
| Mitral Valve Insufficiency | 8 | 2023 | 1415 | 1.150 |
Why?
|
| Aortic Valve | 19 | 2021 | 1911 | 1.120 |
Why?
|
| Myocardial Revascularization | 3 | 2020 | 841 | 1.120 |
Why?
|
| Mitral Valve | 8 | 2023 | 1484 | 1.070 |
Why?
|
| Myocardial Infarction | 14 | 2022 | 11690 | 1.000 |
Why?
|
| Coronary Artery Disease | 18 | 2020 | 6454 | 0.990 |
Why?
|
| Cardiology Service, Hospital | 6 | 2016 | 246 | 0.980 |
Why?
|
| Models, Cardiovascular | 6 | 2015 | 994 | 0.950 |
Why?
|
| Humans | 316 | 2023 | 742088 | 0.900 |
Why?
|
| Cause of Death | 18 | 2021 | 3571 | 0.870 |
Why?
|
| Hospitals | 12 | 2022 | 3937 | 0.870 |
Why?
|
| Bayes Theorem | 16 | 2023 | 2303 | 0.800 |
Why?
|
| Patient Readmission | 8 | 2020 | 3111 | 0.790 |
Why?
|
| Data Mining | 2 | 2020 | 537 | 0.770 |
Why?
|
| Medical Audit | 4 | 2016 | 467 | 0.740 |
Why?
|
| Tricuspid Valve | 3 | 2016 | 400 | 0.680 |
Why?
|
| Pneumonia | 4 | 2017 | 2117 | 0.650 |
Why?
|
| Survival Rate | 30 | 2021 | 12773 | 0.650 |
Why?
|
| Information Dissemination | 2 | 2017 | 1100 | 0.620 |
Why?
|
| Medicare | 11 | 2023 | 6532 | 0.620 |
Why?
|
| Mandatory Reporting | 1 | 2018 | 121 | 0.610 |
Why?
|
| Accidents, Traffic | 2 | 2020 | 819 | 0.610 |
Why?
|
| Coronary Disease | 8 | 2020 | 6078 | 0.610 |
Why?
|
| Heart Arrest, Induced | 7 | 2000 | 355 | 0.560 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2016 | 346 | 0.540 |
Why?
|
| Comparative Effectiveness Research | 3 | 2020 | 681 | 0.540 |
Why?
|
| Practice Guidelines as Topic | 12 | 2019 | 7276 | 0.530 |
Why?
|
| Biomedical Research | 9 | 2021 | 3306 | 0.530 |
Why?
|
| Aged | 99 | 2023 | 162944 | 0.520 |
Why?
|
| Consensus | 9 | 2021 | 2935 | 0.510 |
Why?
|
| Clinical Competence | 6 | 2019 | 4681 | 0.490 |
Why?
|
| Guideline Adherence | 6 | 2012 | 2266 | 0.490 |
Why?
|
| Heart Failure | 7 | 2020 | 10856 | 0.480 |
Why?
|
| Specialties, Surgical | 2 | 2022 | 389 | 0.480 |
Why?
|
| Male | 133 | 2023 | 349538 | 0.480 |
Why?
|
| Respiration, Artificial | 3 | 2014 | 2566 | 0.470 |
Why?
|
| Automobile Driving | 1 | 2019 | 431 | 0.470 |
Why?
|
| Hospital Administration | 1 | 2017 | 353 | 0.470 |
Why?
|
| Organizational Culture | 1 | 2017 | 510 | 0.460 |
Why?
|
| Female | 134 | 2023 | 379592 | 0.450 |
Why?
|
| Treatment Outcome | 58 | 2023 | 62966 | 0.450 |
Why?
|
| Surgical Procedures, Operative | 3 | 2014 | 1873 | 0.440 |
Why?
|
| Terminology as Topic | 4 | 2020 | 1548 | 0.440 |
Why?
|
| Adult | 64 | 2023 | 213712 | 0.430 |
Why?
|
| Massachusetts | 15 | 2023 | 8662 | 0.420 |
Why?
|
| Heart Valve Prosthesis | 8 | 2021 | 1486 | 0.420 |
Why?
|
| Survival Analysis | 20 | 2018 | 10248 | 0.420 |
Why?
|
| Preoperative Care | 6 | 2015 | 2245 | 0.420 |
Why?
|
| Morbidity | 13 | 2022 | 1767 | 0.400 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 2014 | 1239 | 0.400 |
Why?
|
| Safety Management | 1 | 2017 | 782 | 0.400 |
Why?
|
| Defibrillators, Implantable | 7 | 2012 | 1440 | 0.400 |
Why?
|
| Moral Obligations | 1 | 2012 | 96 | 0.400 |
Why?
|
| Aged, 80 and over | 39 | 2021 | 57683 | 0.400 |
Why?
|
| Heart Diseases | 2 | 2017 | 2789 | 0.390 |
Why?
|
| Renal Insufficiency | 2 | 2014 | 802 | 0.380 |
Why?
|
| Angioplasty, Balloon, Coronary | 3 | 2012 | 1873 | 0.370 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2018 | 1573 | 0.360 |
Why?
|
| Patient Discharge | 3 | 2020 | 3300 | 0.360 |
Why?
|
| Predictive Value of Tests | 16 | 2021 | 15056 | 0.350 |
Why?
|
| Evidence-Based Medicine | 9 | 2019 | 3611 | 0.350 |
Why?
|
| Troponin T | 1 | 2014 | 749 | 0.340 |
Why?
|
| Hospitals, Urban | 1 | 2011 | 499 | 0.340 |
Why?
|
| Risk Factors | 43 | 2022 | 72145 | 0.340 |
Why?
|
| Databases as Topic | 4 | 2018 | 475 | 0.330 |
Why?
|
| Angiography | 3 | 2019 | 1636 | 0.330 |
Why?
|
| Algorithms | 8 | 2021 | 13853 | 0.320 |
Why?
|
| Hospital Bed Capacity | 2 | 2017 | 213 | 0.320 |
Why?
|
| Pneumonectomy | 4 | 2019 | 1093 | 0.320 |
Why?
|
| Health Plan Implementation | 1 | 2011 | 351 | 0.320 |
Why?
|
| Time Factors | 31 | 2020 | 40054 | 0.320 |
Why?
|
| Reproducibility of Results | 13 | 2021 | 19862 | 0.310 |
Why?
|
| Heart Neoplasms | 3 | 2000 | 374 | 0.310 |
Why?
|
| Pancoast Syndrome | 2 | 2003 | 8 | 0.310 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2012 | 1517 | 0.310 |
Why?
|
| Commission on Professional and Hospital Activities | 1 | 2007 | 6 | 0.300 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2008 | 250 | 0.300 |
Why?
|
| Heart Valves | 4 | 2021 | 291 | 0.300 |
Why?
|
| Stroke | 10 | 2023 | 9963 | 0.300 |
Why?
|
| Total Quality Management | 3 | 2019 | 274 | 0.290 |
Why?
|
| Comorbidity | 9 | 2016 | 10372 | 0.280 |
Why?
|
| Academic Medical Centers | 2 | 2017 | 2749 | 0.280 |
Why?
|
| Referral and Consultation | 3 | 2012 | 3527 | 0.280 |
Why?
|
| Aortic Diseases | 5 | 2013 | 741 | 0.280 |
Why?
|
| Ethics, Medical | 1 | 2011 | 791 | 0.270 |
Why?
|
| Fibroma | 2 | 2000 | 212 | 0.270 |
Why?
|
| Middle Aged | 67 | 2021 | 213127 | 0.270 |
Why?
|
| Acute Disease | 2 | 2016 | 7141 | 0.270 |
Why?
|
| Reoperation | 5 | 2020 | 4200 | 0.260 |
Why?
|
| Leadership | 3 | 2021 | 1357 | 0.260 |
Why?
|
| Health Services Needs and Demand | 1 | 2013 | 1411 | 0.260 |
Why?
|
| Hospital Costs | 4 | 2021 | 980 | 0.250 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2011 | 1204 | 0.250 |
Why?
|
| Physicians | 3 | 2015 | 4554 | 0.250 |
Why?
|
| Hospitalization | 9 | 2023 | 10232 | 0.250 |
Why?
|
| Education, Medical | 1 | 2016 | 1717 | 0.250 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 1431 | 0.250 |
Why?
|
| Public Health | 1 | 2017 | 2594 | 0.240 |
Why?
|
| Logistic Models | 12 | 2018 | 13403 | 0.240 |
Why?
|
| Risk | 6 | 2016 | 9679 | 0.240 |
Why?
|
| Mammary Arteries | 2 | 2019 | 70 | 0.240 |
Why?
|
| Cardiopulmonary Bypass | 6 | 2020 | 1066 | 0.230 |
Why?
|
| Decision Making | 1 | 2017 | 3869 | 0.230 |
Why?
|
| Follow-Up Studies | 28 | 2019 | 39004 | 0.230 |
Why?
|
| Atrial Fibrillation | 5 | 2018 | 5019 | 0.230 |
Why?
|
| Japan | 3 | 2020 | 1360 | 0.220 |
Why?
|
| Echocardiography | 7 | 2019 | 5097 | 0.220 |
Why?
|
| Peripheral Arterial Disease | 2 | 2010 | 1184 | 0.220 |
Why?
|
| Myelolipoma | 1 | 2002 | 12 | 0.220 |
Why?
|
| Aorta, Thoracic | 5 | 2018 | 1080 | 0.220 |
Why?
|
| Program Development | 2 | 2008 | 1314 | 0.220 |
Why?
|
| Retrospective Studies | 36 | 2023 | 77098 | 0.210 |
Why?
|
| Forecasting | 5 | 2019 | 2948 | 0.210 |
Why?
|
| Surgery Department, Hospital | 1 | 2004 | 175 | 0.210 |
Why?
|
| Social Security | 2 | 2013 | 100 | 0.210 |
Why?
|
| Gait | 3 | 2016 | 784 | 0.200 |
Why?
|
| Drug Prescriptions | 1 | 2011 | 1636 | 0.200 |
Why?
|
| Survivors | 1 | 2012 | 2286 | 0.200 |
Why?
|
| Medical Records | 1 | 2007 | 1413 | 0.200 |
Why?
|
| California | 3 | 2020 | 1400 | 0.190 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2019 | 941 | 0.190 |
Why?
|
| New York | 2 | 2020 | 886 | 0.190 |
Why?
|
| Endarterectomy, Carotid | 2 | 2020 | 546 | 0.190 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 3 | 2020 | 63 | 0.190 |
Why?
|
| History, 21st Century | 2 | 2018 | 1533 | 0.190 |
Why?
|
| Inpatients | 5 | 2023 | 2495 | 0.190 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2714 | 0.190 |
Why?
|
| Health Status Indicators | 3 | 2018 | 968 | 0.190 |
Why?
|
| Incidence | 16 | 2021 | 20928 | 0.190 |
Why?
|
| Health Policy | 3 | 2015 | 2657 | 0.180 |
Why?
|
| Health Resources | 2 | 2020 | 911 | 0.180 |
Why?
|
| History, 20th Century | 3 | 2018 | 2739 | 0.180 |
Why?
|
| Antibiotic Prophylaxis | 3 | 2014 | 638 | 0.180 |
Why?
|
| Models, Econometric | 1 | 2000 | 219 | 0.180 |
Why?
|
| Internationality | 2 | 2017 | 1002 | 0.180 |
Why?
|
| Treatment Failure | 2 | 2023 | 2615 | 0.180 |
Why?
|
| Patient Satisfaction | 4 | 2013 | 3391 | 0.180 |
Why?
|
| Cardiovascular Diseases | 8 | 2015 | 15108 | 0.170 |
Why?
|
| Severity of Illness Index | 8 | 2021 | 15530 | 0.170 |
Why?
|
| Data Display | 2 | 2011 | 182 | 0.170 |
Why?
|
| ROC Curve | 3 | 2021 | 3528 | 0.170 |
Why?
|
| Wound Infection | 1 | 2021 | 240 | 0.170 |
Why?
|
| Blood Vessel Prosthesis | 4 | 1994 | 933 | 0.170 |
Why?
|
| S100 Proteins | 1 | 2000 | 259 | 0.170 |
Why?
|
| Vocabulary, Controlled | 1 | 2020 | 170 | 0.170 |
Why?
|
| Prognosis | 15 | 2021 | 29010 | 0.170 |
Why?
|
| Research Report | 2 | 2020 | 355 | 0.170 |
Why?
|
| Sulfurtransferases | 1 | 2018 | 17 | 0.160 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2015 | 2267 | 0.160 |
Why?
|
| Combined Modality Therapy | 7 | 2018 | 8621 | 0.160 |
Why?
|
| Odds Ratio | 7 | 2018 | 9846 | 0.160 |
Why?
|
| Hypothermia, Induced | 6 | 2000 | 747 | 0.160 |
Why?
|
| Cohort Studies | 14 | 2023 | 40450 | 0.160 |
Why?
|
| Health Care Surveys | 4 | 2021 | 2451 | 0.160 |
Why?
|
| Radial Artery | 1 | 2019 | 194 | 0.160 |
Why?
|
| Diagnosis-Related Groups | 3 | 2016 | 454 | 0.160 |
Why?
|
| Multivariate Analysis | 9 | 2018 | 12242 | 0.150 |
Why?
|
| Feedback | 2 | 2011 | 793 | 0.150 |
Why?
|
| Paraplegia | 1 | 1998 | 168 | 0.150 |
Why?
|
| Sensitivity and Specificity | 8 | 2019 | 14720 | 0.150 |
Why?
|
| Electric Countershock | 4 | 1996 | 535 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 3 | 2011 | 7153 | 0.150 |
Why?
|
| Israel | 2 | 2017 | 795 | 0.150 |
Why?
|
| Paresis | 1 | 1998 | 179 | 0.150 |
Why?
|
| Aorta | 3 | 2012 | 2057 | 0.150 |
Why?
|
| Mortality | 3 | 2020 | 2857 | 0.150 |
Why?
|
| Accreditation | 1 | 2020 | 449 | 0.150 |
Why?
|
| Patient Transfer | 2 | 2014 | 760 | 0.140 |
Why?
|
| Postoperative Period | 4 | 2016 | 1839 | 0.140 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2018 | 143 | 0.140 |
Why?
|
| Costs and Cost Analysis | 2 | 2020 | 1679 | 0.140 |
Why?
|
| Thoracotomy | 2 | 1995 | 363 | 0.140 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 24913 | 0.140 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3507 | 0.140 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 515 | 0.140 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2014 | 687 | 0.140 |
Why?
|
| Hemothorax | 2 | 1993 | 59 | 0.140 |
Why?
|
| Kidd Blood-Group System | 1 | 1995 | 1 | 0.140 |
Why?
|
| Sex Factors | 6 | 2016 | 10392 | 0.130 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2016 | 93 | 0.130 |
Why?
|
| International Classification of Diseases | 2 | 2014 | 865 | 0.130 |
Why?
|
| Endarterectomy | 1 | 1996 | 195 | 0.130 |
Why?
|
| Acute Coronary Syndrome | 3 | 2013 | 2337 | 0.130 |
Why?
|
| Anniversaries and Special Events | 1 | 2015 | 89 | 0.130 |
Why?
|
| Carotid Stenosis | 2 | 2020 | 854 | 0.130 |
Why?
|
| Radiography | 11 | 2008 | 7010 | 0.130 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 1996 | 73 | 0.130 |
Why?
|
| Iran | 1 | 2018 | 704 | 0.130 |
Why?
|
| Patient Admission | 2 | 2014 | 1380 | 0.130 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 1988 | 219 | 0.130 |
Why?
|
| Choice Behavior | 1 | 2000 | 802 | 0.120 |
Why?
|
| Staphylococcal Infections | 2 | 2014 | 1398 | 0.120 |
Why?
|
| Mitral Valve Stenosis | 1 | 2016 | 376 | 0.120 |
Why?
|
| Patient Care Team | 2 | 2019 | 2527 | 0.120 |
Why?
|
| Age Factors | 7 | 2016 | 18355 | 0.120 |
Why?
|
| Inservice Training | 1 | 2017 | 392 | 0.120 |
Why?
|
| Medical Errors | 1 | 2023 | 1296 | 0.120 |
Why?
|
| Ischemic Attack, Transient | 1 | 2020 | 934 | 0.120 |
Why?
|
| Lung Neoplasms | 5 | 2019 | 13019 | 0.120 |
Why?
|
| Continuity of Patient Care | 1 | 2021 | 1048 | 0.120 |
Why?
|
| Perioperative Care | 2 | 2019 | 997 | 0.120 |
Why?
|
| Propensity Score | 3 | 2017 | 1771 | 0.120 |
Why?
|
| Intraoperative Period | 2 | 2013 | 520 | 0.110 |
Why?
|
| Surgical Wound Infection | 3 | 2015 | 1538 | 0.110 |
Why?
|
| Catheter Ablation | 2 | 2018 | 2746 | 0.110 |
Why?
|
| Antiphospholipid Syndrome | 1 | 1995 | 173 | 0.110 |
Why?
|
| Hemolysis | 1 | 1995 | 420 | 0.110 |
Why?
|
| Likelihood Functions | 1 | 2016 | 1003 | 0.110 |
Why?
|
| Cephalosporins | 1 | 2014 | 203 | 0.110 |
Why?
|
| Goiter, Substernal | 2 | 1992 | 17 | 0.110 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2016 | 273 | 0.110 |
Why?
|
| Aortic Aneurysm | 4 | 1994 | 643 | 0.110 |
Why?
|
| Thoracic Neoplasms | 2 | 2008 | 268 | 0.110 |
Why?
|
| Hernia, Hiatal | 1 | 1993 | 79 | 0.110 |
Why?
|
| Length of Stay | 7 | 2021 | 6294 | 0.110 |
Why?
|
| Bronchogenic Cyst | 1 | 1992 | 29 | 0.110 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2015 | 475 | 0.110 |
Why?
|
| Quality Control | 2 | 2010 | 841 | 0.110 |
Why?
|
| Sample Size | 2 | 2016 | 844 | 0.110 |
Why?
|
| Postoperative Care | 3 | 2018 | 1484 | 0.110 |
Why?
|
| Neoadjuvant Therapy | 1 | 2003 | 2721 | 0.110 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 1998 | 685 | 0.110 |
Why?
|
| Workflow | 1 | 2017 | 846 | 0.100 |
Why?
|
| Carotid Arteries | 1 | 1996 | 952 | 0.100 |
Why?
|
| Mobility Limitation | 1 | 2016 | 405 | 0.100 |
Why?
|
| Vena Cava, Superior | 1 | 1992 | 194 | 0.100 |
Why?
|
| Lung Abscess | 1 | 1991 | 42 | 0.100 |
Why?
|
| Echocardiography, Doppler | 1 | 2015 | 934 | 0.100 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2013 | 578 | 0.100 |
Why?
|
| Aorta, Abdominal | 3 | 1994 | 645 | 0.100 |
Why?
|
| Isoantibodies | 1 | 1995 | 680 | 0.100 |
Why?
|
| Bronchial Fistula | 1 | 1991 | 85 | 0.100 |
Why?
|
| Frail Elderly | 2 | 2016 | 691 | 0.100 |
Why?
|
| alpha-2-Antiplasmin | 1 | 1990 | 13 | 0.100 |
Why?
|
| Vancomycin | 1 | 2014 | 500 | 0.090 |
Why?
|
| Prosthesis Failure | 2 | 2014 | 1203 | 0.090 |
Why?
|
| Healthcare Disparities | 2 | 2016 | 3151 | 0.090 |
Why?
|
| Vocabulary | 1 | 2011 | 167 | 0.090 |
Why?
|
| Qualitative Research | 1 | 2019 | 2680 | 0.090 |
Why?
|
| alpha-Macroglobulins | 1 | 1990 | 64 | 0.090 |
Why?
|
| Pancreatic Fistula | 1 | 1991 | 145 | 0.090 |
Why?
|
| Laser Therapy | 3 | 2004 | 1071 | 0.090 |
Why?
|
| Angina Pectoris | 2 | 2004 | 977 | 0.090 |
Why?
|
| Pulmonary Edema | 1 | 1993 | 415 | 0.090 |
Why?
|
| Erythrocyte Transfusion | 1 | 1995 | 565 | 0.090 |
Why?
|
| Fibrinolysin | 1 | 1990 | 131 | 0.090 |
Why?
|
| Coronary Restenosis | 1 | 2013 | 424 | 0.090 |
Why?
|
| Femoral Artery | 3 | 2013 | 843 | 0.090 |
Why?
|
| Cerebrovascular Disorders | 1 | 1996 | 1499 | 0.090 |
Why?
|
| Vena Cava, Inferior | 2 | 1990 | 436 | 0.090 |
Why?
|
| Clinical Medicine | 1 | 2011 | 147 | 0.090 |
Why?
|
| Calcinosis | 2 | 1996 | 1497 | 0.090 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 1998 | 1181 | 0.090 |
Why?
|
| Resuscitation Orders | 1 | 2011 | 267 | 0.080 |
Why?
|
| Personal Autonomy | 1 | 2011 | 297 | 0.080 |
Why?
|
| Esophageal Neoplasms | 4 | 1991 | 1581 | 0.080 |
Why?
|
| Gastroesophageal Reflux | 2 | 1993 | 782 | 0.080 |
Why?
|
| Drug Substitution | 1 | 2011 | 281 | 0.080 |
Why?
|
| Social Responsibility | 1 | 2011 | 389 | 0.080 |
Why?
|
| Hematoma | 1 | 1993 | 755 | 0.080 |
Why?
|
| Patient Selection | 6 | 2019 | 4214 | 0.080 |
Why?
|
| Validation Studies as Topic | 1 | 2008 | 159 | 0.080 |
Why?
|
| Cross Infection | 1 | 2017 | 1413 | 0.080 |
Why?
|
| Linear Models | 3 | 2022 | 5948 | 0.080 |
Why?
|
| Emergency Treatment | 1 | 2012 | 517 | 0.080 |
Why?
|
| Polytetrafluoroethylene | 1 | 2008 | 233 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 1952 | 0.080 |
Why?
|
| Causality | 2 | 2008 | 1265 | 0.080 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 1989 | 162 | 0.080 |
Why?
|
| Hospitals, General | 1 | 2012 | 749 | 0.080 |
Why?
|
| Congenital Abnormalities | 1 | 1992 | 707 | 0.080 |
Why?
|
| Residence Characteristics | 1 | 2017 | 2049 | 0.080 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 839 | 0.080 |
Why?
|
| Child | 14 | 2022 | 77478 | 0.080 |
Why?
|
| Laboratories | 1 | 2011 | 461 | 0.080 |
Why?
|
| Health Status | 2 | 2018 | 4030 | 0.070 |
Why?
|
| Patient Care | 1 | 2013 | 639 | 0.070 |
Why?
|
| Myocardial Reperfusion | 1 | 2008 | 351 | 0.070 |
Why?
|
| Stroke Volume | 3 | 2012 | 4983 | 0.070 |
Why?
|
| Infant | 9 | 2020 | 35070 | 0.070 |
Why?
|
| Policy | 1 | 2011 | 504 | 0.070 |
Why?
|
| Blood Coagulation Disorders | 1 | 1990 | 337 | 0.070 |
Why?
|
| Guidelines as Topic | 2 | 2011 | 1402 | 0.070 |
Why?
|
| Medicaid | 3 | 2015 | 2716 | 0.070 |
Why?
|
| Heart Atria | 2 | 1990 | 1348 | 0.070 |
Why?
|
| Child, Preschool | 9 | 2020 | 40955 | 0.070 |
Why?
|
| Drugs, Generic | 1 | 2011 | 422 | 0.070 |
Why?
|
| Proportional Hazards Models | 6 | 2018 | 12344 | 0.070 |
Why?
|
| Lipoma | 1 | 2008 | 334 | 0.070 |
Why?
|
| Public Relations | 1 | 2005 | 22 | 0.070 |
Why?
|
| North America | 3 | 2017 | 1249 | 0.070 |
Why?
|
| Prostheses and Implants | 3 | 2008 | 1385 | 0.070 |
Why?
|
| Agglutinins | 1 | 1985 | 29 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 4029 | 0.070 |
Why?
|
| Potassium Compounds | 1 | 1985 | 40 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 6534 | 0.070 |
Why?
|
| Product Surveillance, Postmarketing | 3 | 2015 | 430 | 0.070 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 950 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2000 | 4030 | 0.060 |
Why?
|
| Infant, Newborn | 7 | 2022 | 25575 | 0.060 |
Why?
|
| Certification | 1 | 2008 | 423 | 0.060 |
Why?
|
| Disclosure | 2 | 2008 | 736 | 0.060 |
Why?
|
| Quebec | 2 | 2015 | 133 | 0.060 |
Why?
|
| Mandatory Programs | 1 | 2005 | 87 | 0.060 |
Why?
|
| Young Adult | 6 | 2019 | 56350 | 0.060 |
Why?
|
| Confidentiality | 1 | 2009 | 609 | 0.060 |
Why?
|
| Statistics as Topic | 2 | 2015 | 2372 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5304 | 0.060 |
Why?
|
| Data Collection | 3 | 2013 | 3339 | 0.060 |
Why?
|
| Prospective Studies | 9 | 2018 | 53187 | 0.060 |
Why?
|
| Outpatients | 1 | 2012 | 1483 | 0.060 |
Why?
|
| Vascular Surgical Procedures | 1 | 2013 | 1473 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 1503 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2015 | 2145 | 0.060 |
Why?
|
| Carotid Artery Diseases | 1 | 2010 | 882 | 0.060 |
Why?
|
| Disability Evaluation | 1 | 2011 | 1827 | 0.060 |
Why?
|
| Assisted Circulation | 1 | 1983 | 104 | 0.060 |
Why?
|
| Internal Medicine | 1 | 2010 | 1009 | 0.060 |
Why?
|
| Graft Survival | 1 | 2014 | 3733 | 0.060 |
Why?
|
| State Government | 1 | 2005 | 369 | 0.050 |
Why?
|
| Anesthesia | 2 | 2011 | 1548 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1995 | 2099 | 0.050 |
Why?
|
| Biological Products | 1 | 2011 | 856 | 0.050 |
Why?
|
| Probability | 2 | 2004 | 2502 | 0.050 |
Why?
|
| Disabled Persons | 1 | 2012 | 1209 | 0.050 |
Why?
|
| Vision Disorders | 1 | 1989 | 1057 | 0.050 |
Why?
|
| Health Care Reform | 1 | 2011 | 1261 | 0.050 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2012 | 1384 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 2275 | 0.050 |
Why?
|
| Models, Theoretical | 2 | 2019 | 3584 | 0.050 |
Why?
|
| Disease Management | 3 | 2021 | 2450 | 0.050 |
Why?
|
| Esophageal Fistula | 1 | 1981 | 64 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5171 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2014 | 4393 | 0.050 |
Why?
|
| Canada | 2 | 2019 | 2061 | 0.050 |
Why?
|
| Heart Arrest | 2 | 1991 | 1469 | 0.050 |
Why?
|
| Interdisciplinary Studies | 1 | 2021 | 89 | 0.050 |
Why?
|
| Drainage | 2 | 1998 | 1140 | 0.050 |
Why?
|
| Angina, Unstable | 1 | 1985 | 926 | 0.050 |
Why?
|
| Hypothyroidism | 1 | 2005 | 659 | 0.050 |
Why?
|
| Clinical Trials as Topic | 3 | 2011 | 7901 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2009 | 6452 | 0.040 |
Why?
|
| Chest Tubes | 2 | 2006 | 150 | 0.040 |
Why?
|
| Perfusion | 2 | 2000 | 1359 | 0.040 |
Why?
|
| Utilization Review | 1 | 2001 | 392 | 0.040 |
Why?
|
| Heart-Assist Devices | 1 | 1990 | 1194 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2005 | 744 | 0.040 |
Why?
|
| Cardiac Care Facilities | 1 | 2019 | 35 | 0.040 |
Why?
|
| Fistula | 1 | 1981 | 218 | 0.040 |
Why?
|
| Annual Reports as Topic | 1 | 2018 | 33 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2021 | 981 | 0.040 |
Why?
|
| Methods | 2 | 1995 | 1128 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2000 | 933 | 0.040 |
Why?
|
| Papaverine | 1 | 1998 | 46 | 0.040 |
Why?
|
| Electronic Health Records | 2 | 2015 | 4440 | 0.040 |
Why?
|
| Renal Artery | 1 | 1980 | 398 | 0.040 |
Why?
|
| Bronchial Neoplasms | 1 | 1979 | 112 | 0.040 |
Why?
|
| Credentialing | 1 | 2019 | 126 | 0.040 |
Why?
|
| Internship and Residency | 2 | 2014 | 5774 | 0.040 |
Why?
|
| Postoperative Hemorrhage | 2 | 2016 | 409 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2011 | 3679 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 1998 | 303 | 0.040 |
Why?
|
| Sulfotransferases | 1 | 2018 | 151 | 0.040 |
Why?
|
| Learning Curve | 1 | 2019 | 200 | 0.040 |
Why?
|
| Hemodynamics | 2 | 2019 | 4197 | 0.040 |
Why?
|
| Intraoperative Care | 3 | 1990 | 766 | 0.040 |
Why?
|
| Anticoagulants | 1 | 1992 | 4595 | 0.040 |
Why?
|
| General Surgery | 1 | 2008 | 1633 | 0.040 |
Why?
|
| Research Design | 1 | 2013 | 5979 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 1986 | 1327 | 0.040 |
Why?
|
| Esophagus | 2 | 1990 | 1017 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2010 | 3067 | 0.040 |
Why?
|
| Pericardium | 1 | 1981 | 667 | 0.040 |
Why?
|
| Gastrectomy | 1 | 1981 | 652 | 0.040 |
Why?
|
| Barrett Esophagus | 2 | 1991 | 494 | 0.040 |
Why?
|
| Amrinone | 1 | 1996 | 14 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2012 | 3428 | 0.040 |
Why?
|
| Tetracycline | 2 | 1994 | 214 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2005 | 1368 | 0.030 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2019 | 269 | 0.030 |
Why?
|
| Decision Trees | 1 | 2018 | 506 | 0.030 |
Why?
|
| Diagnosis, Differential | 3 | 2008 | 12958 | 0.030 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1980 | 793 | 0.030 |
Why?
|
| Venous Cutdown | 1 | 1995 | 6 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2015 | 1679 | 0.030 |
Why?
|
| Sclerotherapy | 2 | 1994 | 175 | 0.030 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 2 | 1992 | 66 | 0.030 |
Why?
|
| Anemia | 1 | 2005 | 1499 | 0.030 |
Why?
|
| Tachycardia, Ventricular | 1 | 2004 | 1272 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2019 | 574 | 0.030 |
Why?
|
| Carcinoma | 2 | 1990 | 2374 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 1 | 1998 | 534 | 0.030 |
Why?
|
| New England | 1 | 2018 | 1021 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 1987 | 3465 | 0.030 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1990 | 3123 | 0.030 |
Why?
|
| Risk Management | 1 | 2018 | 571 | 0.030 |
Why?
|
| Ventricular Pressure | 1 | 2015 | 199 | 0.030 |
Why?
|
| Managed Care Programs | 1 | 2000 | 949 | 0.030 |
Why?
|
| Convalescence | 1 | 1995 | 105 | 0.030 |
Why?
|
| Calibration | 1 | 1997 | 815 | 0.030 |
Why?
|
| Travel | 1 | 2000 | 788 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 1996 | 458 | 0.030 |
Why?
|
| Hematocrit | 1 | 1996 | 636 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 932 | 0.030 |
Why?
|
| Interinstitutional Relations | 1 | 2015 | 240 | 0.030 |
Why?
|
| Sternum | 1 | 1995 | 175 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 2015 | 284 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 1998 | 976 | 0.030 |
Why?
|
| Pleural Effusion | 2 | 1994 | 338 | 0.030 |
Why?
|
| Health Care Sector | 1 | 2015 | 194 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2000 | 1129 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 1990 | 4229 | 0.030 |
Why?
|
| Physical Fitness | 1 | 2018 | 732 | 0.030 |
Why?
|
| Leiomyoma | 1 | 1979 | 728 | 0.030 |
Why?
|
| Prevalence | 3 | 2018 | 15194 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 1998 | 1241 | 0.030 |
Why?
|
| Mood Disorders | 1 | 2000 | 1106 | 0.030 |
Why?
|
| Markov Chains | 1 | 2016 | 969 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1995 | 362 | 0.030 |
Why?
|
| Aspirin | 1 | 2005 | 3278 | 0.030 |
Why?
|
| Pulmonary Veins | 2 | 2016 | 759 | 0.030 |
Why?
|
| Electrodes, Implanted | 2 | 1995 | 824 | 0.030 |
Why?
|
| Brain | 1 | 2000 | 26343 | 0.030 |
Why?
|
| Monitoring, Physiologic | 3 | 2012 | 1737 | 0.030 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1993 | 60 | 0.030 |
Why?
|
| Workload | 1 | 2019 | 849 | 0.030 |
Why?
|
| Societies | 1 | 2013 | 104 | 0.030 |
Why?
|
| Foundations | 1 | 2013 | 94 | 0.030 |
Why?
|
| Epinephrine | 1 | 1996 | 793 | 0.030 |
Why?
|
| Pulmonary Valve | 1 | 2016 | 437 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 2 | 2015 | 5385 | 0.030 |
Why?
|
| Hypotension | 1 | 1998 | 880 | 0.030 |
Why?
|
| Pleural Diseases | 1 | 1993 | 139 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2019 | 2110 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2016 | 764 | 0.030 |
Why?
|
| Respiration Disorders | 1 | 1995 | 370 | 0.030 |
Why?
|
| Ventricular Function, Left | 3 | 2015 | 3656 | 0.030 |
Why?
|
| Body Temperature | 2 | 1985 | 776 | 0.030 |
Why?
|
| Electric Power Supplies | 1 | 1992 | 99 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 2015 | 592 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 1998 | 941 | 0.020 |
Why?
|
| Therapeutic Equivalency | 1 | 2011 | 145 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 1997 | 2970 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2016 | 1254 | 0.020 |
Why?
|
| Pericarditis | 1 | 1992 | 128 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 1997 | 996 | 0.020 |
Why?
|
| Potassium | 2 | 1985 | 1336 | 0.020 |
Why?
|
| Ultrasonic Therapy | 1 | 1993 | 235 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 1997 | 3510 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 1994 | 985 | 0.020 |
Why?
|
| Veins | 1 | 1995 | 769 | 0.020 |
Why?
|
| England | 1 | 2012 | 523 | 0.020 |
Why?
|
| Conflict of Interest | 1 | 2015 | 542 | 0.020 |
Why?
|
| State Medicine | 1 | 2012 | 220 | 0.020 |
Why?
|
| Ankle Brachial Index | 1 | 2010 | 154 | 0.020 |
Why?
|
| Observation | 1 | 2012 | 312 | 0.020 |
Why?
|
| Quality of Life | 1 | 2011 | 12730 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2015 | 1585 | 0.020 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2015 | 859 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1998 | 1807 | 0.020 |
Why?
|
| Hemostasis, Surgical | 1 | 1990 | 128 | 0.020 |
Why?
|
| Pulmonary Embolism | 2 | 1992 | 2370 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 1990 | 212 | 0.020 |
Why?
|
| Communication | 1 | 2023 | 3728 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2016 | 1232 | 0.020 |
Why?
|
| Phlebography | 1 | 1990 | 333 | 0.020 |
Why?
|
| Retinal Artery Occlusion | 1 | 1989 | 74 | 0.020 |
Why?
|
| Angioplasty | 1 | 2011 | 364 | 0.020 |
Why?
|
| Electrocardiography | 4 | 2004 | 6440 | 0.020 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2009 | 99 | 0.020 |
Why?
|
| Ethics, Clinical | 1 | 2009 | 99 | 0.020 |
Why?
|
| Health Services Research | 1 | 2016 | 1834 | 0.020 |
Why?
|
| Ventricular Fibrillation | 1 | 1991 | 538 | 0.020 |
Why?
|
| Polyethylene Terephthalates | 1 | 1988 | 116 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2015 | 1183 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2014 | 1181 | 0.020 |
Why?
|
| Ethics Committees, Research | 1 | 2009 | 194 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2000 | 4455 | 0.020 |
Why?
|
| Occipital Lobe | 1 | 1989 | 380 | 0.020 |
Why?
|
| Ethics, Research | 1 | 2009 | 190 | 0.020 |
Why?
|
| Collateral Circulation | 1 | 1988 | 287 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2016 | 2485 | 0.020 |
Why?
|
| Mediastinum | 1 | 1988 | 267 | 0.020 |
Why?
|
| Kidney Diseases | 2 | 2013 | 2145 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1995 | 1541 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2000 | 6974 | 0.020 |
Why?
|
| Cardia | 1 | 1986 | 57 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 1992 | 877 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 11363 | 0.020 |
Why?
|
| Cephalosporin Resistance | 1 | 2006 | 17 | 0.020 |
Why?
|
| Mediastinitis | 1 | 2006 | 48 | 0.020 |
Why?
|
| Syndrome | 1 | 1992 | 3248 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 1912 | 0.020 |
Why?
|
| Goals | 1 | 2011 | 705 | 0.020 |
Why?
|
| Optic Nerve Diseases | 1 | 1989 | 327 | 0.020 |
Why?
|
| Carcinoma in Situ | 1 | 1991 | 802 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1995 | 2452 | 0.020 |
Why?
|
| Weight Gain | 1 | 1996 | 2282 | 0.020 |
Why?
|
| Pacemaker, Artificial | 1 | 1991 | 817 | 0.020 |
Why?
|
| Cryoglobulins | 1 | 1985 | 59 | 0.020 |
Why?
|
| Carcinosarcoma | 1 | 1986 | 108 | 0.020 |
Why?
|
| Vancomycin Resistance | 1 | 2006 | 128 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2015 | 2924 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2013 | 1581 | 0.020 |
Why?
|
| Hemodilution | 1 | 1985 | 114 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2015 | 1852 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 11001 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 1996 | 2623 | 0.020 |
Why?
|
| Government Regulation | 1 | 2009 | 522 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2015 | 2059 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2000 | 6142 | 0.020 |
Why?
|
| Adolescent | 3 | 2019 | 85649 | 0.020 |
Why?
|
| Cerebral Infarction | 1 | 1989 | 1007 | 0.010 |
Why?
|
| Soft Tissue Infections | 1 | 2006 | 155 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1985 | 683 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 6483 | 0.010 |
Why?
|
| Exercise Therapy | 1 | 2010 | 904 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2013 | 1780 | 0.010 |
Why?
|
| Nitrates | 1 | 1985 | 265 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1990 | 1296 | 0.010 |
Why?
|
| Heterozygote | 1 | 1990 | 2790 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1996 | 8297 | 0.010 |
Why?
|
| Bioprosthesis | 1 | 2008 | 596 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 1967 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 2006 | 425 | 0.010 |
Why?
|
| Heart | 1 | 1996 | 4462 | 0.010 |
Why?
|
| Informed Consent | 1 | 2009 | 991 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2012 | 2414 | 0.010 |
Why?
|
| Boston | 1 | 2015 | 9305 | 0.010 |
Why?
|
| Body Size | 1 | 2005 | 461 | 0.010 |
Why?
|
| Prosthesis-Related Infections | 1 | 2008 | 538 | 0.010 |
Why?
|
| Pulmonary Artery | 2 | 1992 | 1911 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 1527 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 7770 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 1985 | 689 | 0.010 |
Why?
|
| Brachiocephalic Veins | 1 | 1981 | 23 | 0.010 |
Why?
|
| Recurrence | 1 | 1993 | 8333 | 0.010 |
Why?
|
| Thyroxine | 1 | 2005 | 666 | 0.010 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2006 | 563 | 0.010 |
Why?
|
| Meta-Analysis as Topic | 1 | 2006 | 1342 | 0.010 |
Why?
|
| Sinus of Valsalva | 1 | 1981 | 58 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 1661 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2010 | 5062 | 0.010 |
Why?
|
| Hypertension, Renovascular | 1 | 1980 | 123 | 0.010 |
Why?
|
| Ischemia | 1 | 1989 | 1911 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1985 | 2552 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1987 | 2876 | 0.010 |
Why?
|
| Aortography | 1 | 1981 | 431 | 0.010 |
Why?
|
| Smoking | 2 | 2013 | 8969 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1987 | 2906 | 0.010 |
Why?
|
| Brachytherapy | 1 | 1987 | 1246 | 0.010 |
Why?
|
| Fibrinolytic Agents | 1 | 1988 | 2156 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1985 | 1869 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 5133 | 0.010 |
Why?
|
| Tachycardia | 2 | 1991 | 620 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 1987 | 9185 | 0.010 |
Why?
|
| Aortic Rupture | 1 | 1981 | 310 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 4929 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 2006 | 1389 | 0.010 |
Why?
|
| Differential Threshold | 1 | 1996 | 80 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1992 | 4029 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 1983 | 1155 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 1981 | 1265 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1991 | 6347 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1996 | 1309 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1988 | 9144 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 1979 | 860 | 0.010 |
Why?
|
| Myocardium | 1 | 1985 | 4775 | 0.010 |
Why?
|
| Calcium | 1 | 1985 | 5753 | 0.010 |
Why?
|
| Primary Myelofibrosis | 1 | 1993 | 214 | 0.010 |
Why?
|
| Obesity | 1 | 2013 | 12705 | 0.010 |
Why?
|
| Debridement | 1 | 1993 | 492 | 0.010 |
Why?
|
| Esophagitis, Peptic | 1 | 1990 | 77 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1985 | 8541 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 9941 | 0.010 |
Why?
|
| Telemetry | 1 | 1990 | 205 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1991 | 853 | 0.010 |
Why?
|
| Esophageal Stenosis | 1 | 1990 | 194 | 0.010 |
Why?
|
| Esophagoscopy | 1 | 1990 | 390 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1992 | 2027 | 0.000 |
Why?
|
| Manometry | 1 | 1990 | 444 | 0.000 |
Why?
|
| Magnetics | 1 | 1990 | 609 | 0.000 |
Why?
|
| Biopsy, Needle | 1 | 1992 | 1640 | 0.000 |
Why?
|
| Mucous Membrane | 1 | 1990 | 670 | 0.000 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1990 | 846 | 0.000 |
Why?
|
| Epithelium | 1 | 1990 | 1680 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1992 | 20086 | 0.000 |
Why?
|
| Population Surveillance | 1 | 1991 | 2616 | 0.000 |
Why?
|
| Alcohol Drinking | 1 | 1991 | 3957 | 0.000 |
Why?
|
| Palliative Care | 1 | 1994 | 3478 | 0.000 |
Why?
|
| Biopsy | 1 | 1986 | 6756 | 0.000 |
Why?
|
| Lung | 1 | 1992 | 9826 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1992 | 35342 | 0.000 |
Why?
|
| Animals | 1 | 1992 | 168561 | 0.000 |
Why?
|